Lifecore Biomedical (LDE) Ownership - Who Owns Lifecore Biomedical?
Lifecore Biomedical (LDE) Ownership Overview
- 15.99% Insiders
- 6.48% Mutual Funds
- 0.31% Other Institutional Investors
- 7.30% ETFs
- 69.92% Public Companies and Individual Investors
The ownership structure of Lifecore Biomedical (DE:LDE) stock is a mix of institutional, retail, and individual investors. Approximately 14.08% of the company’s stock is owned by Institutional Investors, 15.99% is owned by Insiders, and 69.92% is owned by Public Companies and Individual Investors.
The ownership structure of Lifecore Biomedical (DE:LDE) stock is a mix of institutional, retail, and individual investors. Approximately 14.08% of the company’s stock is owned by Institutional Investors, 15.99% is owned by Insiders, and 69.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €111,084 | |
| Dec 31, 2025 | Gamco Investors, Inc. Et Al | €685,484 | |
| Dec 31, 2025 | Greenhaven Road Investment Management, L.p. | €30,123,447 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Christopher S Kiper | 4,507,236 | Insider | 11.89% | 28,688,557 |
| Christopher Kiper | 4,461,823 | Institution | 11.77% | 28,399,503 |
| Scott Miller | 3,190,769 | Institution | 8.42% | 20,309,245 |
| BlackRock, Inc. | 2,013,093 | Institution | 5.31% | 12,813,337 |
| Vanguard | 1,451,279 | Institution | 3.83% | 9,237,391 |
| Vanguard Index Funds | 1,257,515 | Institution | 3.32% | 8,004,083 |
| Ishares | 1,156,920 | Institution | 3.05% | 7,363,796 |
| Paul Josephs | 592,915 | Insider | 1.56% | 3,773,904 |
| Fidelity Concord Street Trust | 362,889 | Institution | 0.96% | 2,309,788 |
| Fidelity Salem Street Trust | 347,108 | Institution | 0.92% | 2,209,342 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,257,515 | Institution | 3.32% | 8,004,083 |
| Fidelity Concord Street Trust | 362,889 | Institution | 0.96% | 2,309,788 |
| Fidelity Salem Street Trust | 347,108 | Institution | 0.92% | 2,209,342 |
| Vanguard Scottsdale Funds | 191,706 | Institution | 0.51% | 1,220,209 |
| Schwab Capital Trust | 87,524 | Institution | 0.23% | 557,090 |
| Bridgeway Funds, Inc. | 56,900 | Institution | 0.15% | 362,169 |
| Tiaa-cref Funds | 35,850 | Institution | 0.09% | 228,185 |
| Goldman Sachs Trust | 26,154 | Institution | 0.07% | 166,470 |
| Vanguard Institutional Index Funds | 15,740 | Institution | 0.04% | 100,185 |
| Vanguard Valley Forge Funds | 15,366 | Institution | 0.04% | 97,805 |
FAQ
Who Owns Lifecore Biomedical (DE:LDE)?
According to the latest TipRanks data, approximately 14.08% of the company's stock is held by institutional investors, 15.99% is held by insiders, and 69.92% is held by public companies and individual investors.
What percentage of Lifecore Biomedical (DE:LDE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.08% of Lifecore Biomedical (DE:LDE) stock is held by institutional investors: 6.48% by mutual funds, 7.30% by ETFs and 0.31% by other institutional investors.
What percentage of Lifecore Biomedical (DE:LDE) stock is held by retail investors?
According to the latest TipRanks data, approximately 69.92% of Lifecore Biomedical (DE:LDE) stock is held by public companies and individual investors.
Who owns the most shares of Lifecore Biomedical (DE:LDE)?
Christopher S Kiper owns the most shares of Lifecore Biomedical (DE:LDE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
